4//SEC Filing
Egan James 4
Accession 0001209191-09-045932
CIK 0001365216other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 5:16 PM ET
Size
10.7 KB
Accession
0001209191-09-045932
Insider Transaction Report
Form 4
Egan James
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2009-09-16+7,000→ 7,000 totalExercise: $4.99Exp: 2019-09-16→ Class A common stock (7,000 underlying) - Award
Employee Stock Option (Right to buy)
2009-09-14+60,000→ 60,000 totalExercise: $4.98Exp: 2019-09-14→ Class A common stock (60,000 underlying) - Award
Employee Stock Option (Right to buy)
2009-09-23+60,000→ 60,000 totalExercise: $5.87Exp: 2019-09-23→ Class A common stock (60,000 underlying)
Footnotes (3)
- [F1]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2010 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2011 in four equal annual installments.
- [F2]Vesting commences on September 16, 2010 in four equal annual installments.
- [F3]With regard to 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2012 in four equal annual installments and with regard to the balance of 30,000 shares of Class A common stock underlying the option, vesting commences on September 14, 2013 in four equal annual installments.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeother
Related Parties
1- filerCIK 0001296997
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 5:16 PM ET
- Size
- 10.7 KB